Search
News
SG Morning Call｜Singapore Stocks Opened Lower On Wednesday. SUTL Enterprise Up 4%; SingPost Up 1%; Kore Down 2%; ManulifeReit Down 1%
Market SnapshotSingapore stocks opened lower on Wednesday. STI down 0.2%; SUTL Enterprise up 4%; SingPost up 1%; Kore down 2%; ManulifeReit down 1%.Stocks in FocusSembcorp Industries : The energy player on Wednesday said its acquisition of all of CleanCurrent Renewable Energy’s shares in Puente Al ...Tiger News
Wed, Dec 31
Post-Bell｜US Stocks End Down; AGQ Up 9%; SLV, XPeng And Baidu Up 4%; Intel Up 2%; Tesla Down 1%
01 Stock MarketThe U.S. major indexes closed as follows: Dow Jones Industrial Average down 0.20% at 48,367.06; S&P 500 down 0.14% at 6,896.24; Nasdaq Composite down 0.24% at 23,419.08.Unusual-move stocks were mixed, with precious metals ETFs advancing while several mega caps eased. TSLA down 1.13% a...Tiger News
Tue, Dec 30
Meta Shares Gain as It Will Buy Chinese Founded Startup Manus to Boost Advanced AI
Meta said on Monday it would acquire Chinese-founded artificial intelligence startup Manus, as the technology giant accelerates efforts to integrate advanced AI across its platforms.Financial terms of the transaction were not released, but a source with direct knowledge of the matter said the deal v...Tiger News
Tue, Dec 30
Tesla Broadcasts Downbeat Car Sales Estimates in Unusual Move
Tesla published a compilation of analyst estimates for vehicle deliveries to its website, and the averages for the current quarter are more pessimistic than those gathered by Bloomberg.Tesla shares dropped more than 1% in morning trading.By Tesla’s count, analysts on average expect the company to de...Tiger News
Tue, Dec 30
Trump Media Launches Five ETFs on NYSE Through Partnership
Trump Media & Technology Group Corp. (NASDAQ: DJT) launched five exchange-traded funds on the New York Stock Exchange through sponsor Yorkville America Equities. The ETFs are part of Trump Media's Truth.Fi fintech brand.The funds include Truth Social American Security & Defense ETF (TSSD), Truth Soc...Tiger News
Tue, Dec 30
Pre-Bell | U.S. Futures Dip; Gold and Silver Gold and ETFs Rally; Baidu Gains 5%; EKSO Soars 45%
01 Stock MarketAs of Dec 30, U.S. stock index futures are steady to slightly softer across benchmarks. Dow futures were flat, while S&P 500 futures were marginally lower and Nasdaq 100 futures eased modestly, reflecting a cautious tone into the final trading days of the year. The setup suggests trad...Tiger News
Tue, Dec 30
Applied Digital to Spin Out Cloud Business, Proposes Business Combination with EKSO to Launch ChronoScale
Applied Digital and EKSO Bionics Holdings announced Monday they have entered into a non-binding term sheet for a proposed business combination that would merge Applied Digital’s cloud computing business with EKSO to create ChronoScale Corporation, a platform designed for artificial intelligence work...Tiger News
Tue, Dec 30
2025 Recap | Communication Services up 33%, Leading S&P 500; Info Tech up 25%; Industrials up 19%; Financials up 15%
The stock market has had a very good 2025. The S&P 500 index has risen about 17.41% (as of Dec. 29), which is pretty strong considering the average annual gain for that index is about 10%.Three sectors outperformed the broad index during the year. They were information technology (IT), communication...Tiger News
Tue, Dec 30
Uni-Bio Science Joins Forces with WMU NERC and Ouhai District Government to Build Growth Factor Innovation Ecosystem and Accelerate Regenerative Medicine Strategy Layout
[Hong Kong, December 30th, 2025] Uni-Bio Science Group Limited (“Uni-Bio Science Group”, “Uni-Bio” or “the Group”) is pleased to announce the official signing of a tripartite strategic cooperation agreement in Wenzhou, Zhejiang, with the National Engineering Research Center for Cell Growth Factor Drugs and Protein Formulations of Wenzhou Medical University (“WMU NERC”) and the People's Government of Ouhai District, Wenzhou. The parties also explored the subsequent co-establishment of the "Uni-Bio - WMU Joint Innovation Laboratory for Translational Medicine." This collaboration marks a key step for Uni-Bio in deeply integrating with a national-level research platform and a regional industrial ecosystem. Through a synergistic “government-university-enterprise” model, the three parties will focus on the core regenerative medicine field of growth factors to establish an end-to-end innovation system spanning basic research, clinical translation, and industrial application. This represents a milestone for the Group in consolidating its R&D pipeline and accelerating its strategic execution.（Photo: Strategic cooperation signing ceremony group photo）Focusing on Growth Factor Frontiers, Unleashing “1+1>2” Clinical and Market PotentialGrowth factors are key signaling molecules that regulate cell proliferation, migration, and tissue repair, representing some of the most transformative bioactive substances in regenerative medicine. Both EGF (Epidermal Growth Factor) and FGF (Fibroblast Growth Factor) have demonstrated significant efficacy across major indications, including wound healing, ophthalmic diseases, and metabolic disorders, underscoring their substantial market potential. Uni-Bio possesses deep expertise in the EGF field, with its flagship products GeneTime® and GeneSoft® achieving large-scale production and nationwide commercial coverage. Concurrently, under the leadership of Academician Li Xiaokun, the WMU NERC has been a global pioneer in FGF drug R&D, having successfully translated several Class I New Drugs - including Recombinant Human Basic Fibroblast Growth Factor - and has accumulated substantial clinical data and authoritative expert consensus in trauma and metabolic diseases.Building on this foundation, the three parties will initiate collaborative research on combined EGF/FGF therapies for key areas, including burns, dermatology, and ophthalmology. The goal is to unlock powerful therapeutic synergies, develop superior combination products and advance delivery systems, set new treatment benchmarks, and establish a leadership position in shaping this multi-billion Yuan sector.Empowered by Academician Leadership & Platform, Creating a Fast Track from R&D to ProductionThe WMU NERC is an independent legal entity established by Wenzhou Medical University based on the national-level platform, the National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations. It undertakes downstream functions including engineering technology research and development, transformation of scientific and technological achievements, and technical services. In synergistic collaboration with the National Key Laboratory for Macromolecular Drugs and Large-Scale Preparation, which focuses on upstream basic research, the Center has built a next-generation growth factor drug pipeline targeting multiple systems such as metabolism and dermatology. Through the ongoing research of Academician Li Xiaokun’s team, the Center has achieved internationally leading breakthroughs in key technologies, including long-acting Modification, targeted delivery, and aerosol inhalation.The planned "Uni-Bio – WMU Joint Innovation Laboratory for Translational Medicine" will conduct in-depth research into the synergistic mechanisms of Epidermal Growth Factor (EGF) and Fibroblast Growth Factor (FGF) in regulating metabolic homeostasis, improving insulin sensitivity, and promoting tissue repair. It aims to develop novel compound formulations and drug delivery systems targeting conditions such as endocrine diseases represented by non-alcoholic steatohepatitis (NASH), respiratory diseases represented by asthma, as well as bone tissue repair. These diseases affect a large global patient population, yet there remains a significant unmet clinical need for innovative therapies. Through this collaboration, it is expected to address treatment gaps in multiple specific indications, further unlocking clinical and commercial value in the broad chronic disease market.The "Government-University-Enterprise " Trinity, Systematically Strengthening Full-Chain CapabilitiesThis collaboration extends beyond technological synergy to ecosystem co-development. The People's Government of Ouhai District, Wenzhou, is a key facilitator and supporter of this strategic cooperation, committed to building a first-class biomedical industry ecosystem. Its core platform, the "China Gene Valley," will provide comprehensive spatial support and specialized policy assistance for the cooperative projects across all stages – from R&D and pilot-scale testing to industrialization.For Uni-Bio, this tripartite cooperation delivers threefold empowerment:R&D Front: Direct access to the National Engineering Research Center’s source innovation and core technologies, elevating the starting point of R&D. Clinical Front: Collaboration with Wenzhou Medical University’s affiliated hospital network to accelerate clinical validation and indication expansion. Commercialization Front: Leveraging the advanced manufacturing capabilities and regional policy benefits of the China Gene Valley to ensure efficient project implementation and facilitate market access.This strategic partnership is a crucial step in the Group's pursuit of its vision "To Be the Global Leader in Regenerative Medicine, Redefining How Science Restores and Extends Human Life" Moving forward, the Group will continue to deepen collaborations with national scientific institutions and local governments, driving the translation of more cutting-edge research into clinical and market value. This will further consolidate and enhance its comprehensive competitiveness and leadership in regenerative medicine.EndAbout Uni-Bio Science:Uni-Bio Science Group Limited is an innovative biopharmaceutical enterprise listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2001(Stock Code: 00690.HK). The Group is committed to powering the advancement of regenerative medicine with next-generation synthetic biology and complex peptide innovation. Focusing on four core research areas—muscular-skeletal regeneration, skin regeneration, ocular regeneration, and ENT regeneration—the Group has built a diversified product pipeline encompassing innovative biologics, high-value generic drugs, and medical aesthetics. The Group operates GMP-compliant production bases in Beijing, Dongguan, and Shenzhen, with fully integrated capabilities spanning R&D, manufacturing, and commercial sales. Uni-Bio Science Group is dedicated to becoming a global leader in regenerative medicine, redefining how science restores and extends human life.About the National Engineering Research Center for Cell Growth Factor Drugs and Protein Formulations of Wenzhou Medical University:The WMU NERC is an independent legal entity established by Wenzhou Medical University based on the national-level platform, the National Engineering Research Center for Cell Growth Factor Drugs and Protein Preparations. It undertakes downstream functions including engineering technology research and development, transformation of scientific and technological achievements, and technical services. Under the leadership of Chinese Academy of Engineering Academician Li Xiaokun, the Center has long been engaged in foundational research and novel drug discovery for cell growth factor drugs, holding a globally leading position. It brings together top-tier scientific teams, undertakes major national science and technology projects, and has successfully developed a series of innovative FGF drugs with independent intellectual property rights. Through synergistic collaboration with the National Key Laboratory for Macromolecular Drugs and Large‑Scale Preparation, the Center forms a complete innovation chain from source discovery and key technological breakthroughs to industrial translation. As the important R&D engine of the China Gene Valley, it continuously promotes the incubation and translation of several original new drug candidates, including a long-acting FGF21 variant.About the People's Government of Ouhai District, Wenzhou:The People's Government of Ouhai District, Wenzhou, is a key facilitator and supporter of this strategic cooperation, committed to building a first-class biomedical industry ecosystem. Its core platform, the "China Gene Valley," will provide comprehensive spatial support and specialized policy assistance for the cooperative projects across all stages – from R&D and pilot-scale testing to industrialization. Through specialized industrial policies, "full-cycle escort" services, and clinical resource coordination, Ouhai District empowers the implementation and growth of innovation projects, serving as a vital driver for regional biomedical industry innovation and development.30/12/2025 Dissemination of a Financial Press Release, transmitted by EQS News.The issuer is solely responsible for the content of this announcement.Media archive at www.todayir.comEQS
Tue, Dec 30
Gold and Silver Stocks and ETFs Rebound as Precious Metals Bounce; Baidu Shares Jump 5% on AI Chip Report
Gold and silver stocks and ETFs rebounded in premarket trading. Gold Fields rose 3%; Anglogold Ashanti, Hecla Mining, Harmony Gold, and Newmont Mining rose 2%; Barrick Mining, Coeur Mining, and Kinross rose 1%; SPDR Gold ETF rose 0.8%. Endeavour Silver rose 3%; iShares Silver Trust, Pan America...Tiger News
Tue, Dec 30
2025 Recap | Precious Metals Shine! Nasdaq Registers Double-Digit Gains
Precious metals surged in 2025 with silver, gold rising 153% and 66%, respectively. Nasdaq Composite Index gained about 22% while S&P 500 jumped over 17%.Precious metals shineBullion has staged a stellar run in 2025, climbing 66% so far. Interest rate cuts and bets of further U.S. policy easing, geo...Tiger News
Tue, Dec 30
2025 Recap | Chip Stocks Shine! Sandisk Soars 597%, Micron Surges 250%, Nvidia Jumps 40%
Semiconductor stocks delivered outsized gains in 2025, capping a year marked by a sharp rebound in memory-chip makers and continued investor enthusiasm for artificial intelligence-related technologies.Among major chip companies, SanDisk Corp emerged as the standout performer, with its shares rising ...Tiger News
Tue, Dec 30
2025 Recap | Bitcoin ETFs Mostly Show Net Outflows! GBTC Sees $3.7 Billion Net Outflows
With one week left in the books, 2025 is shaping up to be both a successful and disappointing year for U.S.-listed crypto ETFs.On net, crypto ETFs gathered $21.3 billion of inflows during the year-to-date period ending Dec. 29. Those headline numbers, however, mask a more uneven picture beneath the ...Tiger News
Tue, Dec 30
Crypto Daily | Strategy Buys $109M Worth of Bitcoin During Holiday Week; Standard Chartered and Ant Launch 24-Hour Tokenized Deposits
Crypto Daily is our column tracking crypto market trends, offering timely insights and valuable updates to keep you informed.Crypto NewsBitcoin(BTC) Drops to $87,000 with a 3.02% Decrease in 24 HoursBitcoin has dropped to $87,000 and is now trading at $87,298, with a narrowed 3.02% decrease in 24 ho...Tiger News
Tue, Dec 30
Pop Mart Stock Slips 6% As 2nd-Hand Blind Box Prices Plummet Reportedly
POP MART stock fell 6% in Hong Kong trading.According to Chinese media reports, the trendy toy brand Labubu under POP MART saw a plunge in prices for its "Labubu The Monsters Have a Seat Vinyl Plush Series" on second-hand platforms.The average price fell from RMB1,478 to RMB632, with some individual...Tiger News
Tue, Dec 30
3 Stocks Tapping Into the Healthcare Boom
Asia has become the fastest-growing healthcare market globally, and its size is expected to reach 5 trillion US dollars by 2030.This prosperous situation is attributed to the aging trend of the region's population, as well as the continuous expansion of the middle class.With the increasing healthcar...Tiger News
Tue, Dec 30
Featured Tools
Top News
Meta Connect 2026 New Product Roundup: Muse Integrated Into AI Glasses, Can It Drive Meta Revenue Growth?
Apple Stock Price Forecast: Where Is the Next Target Price After Record High as iPhone 18 Pro Series Demand Heats Up?
Micron Earnings Preview: Five Key Things Memory Investors Need to Watch
US Stocks Mixed as Dow Drops 160 Points; Tech Stocks Lead, Meta Rises 4.5%
SK Hynix vs. Micron: Which AI Memory Stock, SKHY or MU, Is Better for Long-Term Holding?
